Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

July 30, 2019 | Daily News

Public Citizen wants the Federal Trade Commission (FTC) to block the merger between Mylan and Pfizer’s Upjohn, which the companies announced Monday (July 29).

July 30, 2019 | Daily News

The leaders of the Senate Finance and health committees met Tuesday (July 30) to begin cross-committee talks on drug pricing, the chairmen said.

July 29, 2019 | Daily News

Drug makers would pay a significantly larger share of costs in Medicare Part D under the Senate Finance Committee’s new drug-pricing plan, according to Senate Finance Chair Chuck Grassley’s (R-IA) office.

July 26, 2019 | Daily News

Senate Finance Chair Chuck Grassley (R-IA) on Thursday (July 25) warned fellow GOP senators that the drug pricing bill he negotiated with ranking Democrat Ron Wyden (OR) is moderate compared to policies being considered by the Trump administration and House Democrats.

July 25, 2019 | Daily News

Freedom Caucus Chair Mark Meadows (R-NC) said Thursday (July 25) it is “very likely” the Trump administration will take its own steps to lower drug prices in Part D, though the details are in flux. Meadows said he attended a drug-pricing meeting Wednesday between President Donald Trump and drug lobbyists that was first reported by Politico.

July 25, 2019 | Daily News

Thirteen Republican senators and one Democrat voted Thursday (July 25) to kill President Donald Trump’s plan to connect Medicare payment for physician-administered drugs to foreign drug prices in a rebuke of one of the administration’s last remaining drug-pricing policies.

July 25, 2019 | Daily News

In a tie vote, an amendment to repeal a key measure of the Senate Finance Committee’s drug-pricing bill failed Thursday (July 25).

July 25, 2019 | Daily News

House Energy & Commerce member William McKinley (R-WV) hopes to eliminate legal barriers to generic market entry through legislation that would narrow the situations in which brand-drug makers can litigate patents while still maintaining intellectual property protections.

July 24, 2019 | Daily News

Acting FDA Commissioner Ned Sharpless told agency staff in an email Tuesday (July 23) that his top priorities are to develop frameworks for regulating new technologies; invest in the agency’s workforce; help to lower drug prices by encouraging drug competition; and improve postmarket surveillance of regulated products.

July 24, 2019 | Daily News

The Senate will not vote on drug pricing legislation before the August recess, key committee chairs said Wednesday (July 23).

July 23, 2019 | Daily News

The White House expressed support on Tuesday (July 23) for the Senate Finance Committee’s new drug-pricing bill as did the generic drug lobby, but the brand-drug lobby came out against it.

July 23, 2019 | Daily News

The Senate Finance Committee unveiled a long-awaited drug-pricing bill, to be marked up Thursday (July 25), that includes monumental changes to drug-pricing policy in Medicare and Medicaid -- including restructuring the Part D benefit, imposing controversial inflationary rebates in Medicare Parts B and D, and raising the rebate cap in Medicaid.

July 23, 2019 | Daily News

Lawmakers on the Senate Finance Committee did not hesitate to criticize the grand drug-pricing bargain Senate Finance Chair Chuck Grassley (R-IA) and ranking Democrat Ron Wyden (OR) rolled out Tuesday (July 23).

July 22, 2019 |

House Speaker Nancy Pelosi’s drug-price negotiation bill will be unveiled in early September to give drug makers less time to undermine the plan over the August recess and the Congressional Budget Office more time to formally score the bill, senior Pelosi aide Wendell Primus said Monday (July 22).

July 22, 2019 | Daily News

The HHS Office of Inspector General says a lack of transparency on which drugs are part of the 340B program may have caused Part D plans to lose tens of millions of dollars in drug rebates from manufacturers in 2014, and the costs to Part D may have increased since because more pharmacies have joined the 340B program.

July 19, 2019 | Daily News

Executives from Pfizer, Genentech, Amgen and Alkermes met with White House officials Thursday (July 18) to discuss policies to control drug prices, according to sources familiar with the meeting.

July 19, 2019 | Daily News

House lawmakers want FDA to expedite its review of drug substances nominated for inclusion on the agency's list of bulk substances that can be compounded based on a clinical need.

July 19, 2019 |

Public Citizen wants the Senate to mandate FDA re-issue the controversial proposed rule on generic drug labeling that it scrapped late last year.

July 19, 2019 | Daily News

The White House asked Democrats late Thursday (July 19) to include in a budget deal Senate Democratic drug-pricing policies that would save the government $115 billion, multiple sources say

July 18, 2019 | Daily News

A pair of researchers from Harvard Medical School call for reforms to the Orphan Drug Act to help stem rising drug prices.

Pages